
Susan Coe Hoffman
Examiner (ID: 8561, Phone: (571)272-0963 , Office: P/1655 )
| Most Active Art Unit | 1655 |
| Art Unit(s) | 1699, 1651, 1654, 1655 |
| Total Applications | 2018 |
| Issued Applications | 924 |
| Pending Applications | 240 |
| Abandoned Applications | 880 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17790887
[patent_doc_number] => 20220249978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => NOVEL SOLVENT FOR EXTRACTING, SOLUBILISING AND/OR FORMULATING VOLATILE AND NON-VOLATILE COMPOUNDS OF INTEREST IN ANIMAL NUTRITION AND HEALTH, PREPARATION METHOD AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/438095
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/438095 | NOVEL SOLVENT FOR EXTRACTING, SOLUBILISING AND/OR FORMULATING VOLATILE AND NON-VOLATILE COMPOUNDS OF INTEREST IN ANIMAL NUTRITION AND HEALTH, PREPARATION METHOD AND USES THEREOF | Mar 9, 2020 | Pending |
Array
(
[id] => 20561961
[patent_doc_number] => 12564551
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-03
[patent_title] => Composition or oat extract comprising avenanthramide and b-glucan
[patent_app_type] => utility
[patent_app_number] => 17/909333
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 23648
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909333 | Composition or oat extract comprising avenanthramide and b-glucan | Mar 5, 2020 | Issued |
Array
(
[id] => 16351832
[patent_doc_number] => 10792324
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Compositions and methods for the treatment of orthopedic ailments
[patent_app_type] => utility
[patent_app_number] => 16/809759
[patent_app_country] => US
[patent_app_date] => 2020-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 10436
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16809759
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/809759 | Compositions and methods for the treatment of orthopedic ailments | Mar 4, 2020 | Issued |
Array
(
[id] => 17576766
[patent_doc_number] => 20220133621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => Cosmetic Composition
[patent_app_type] => utility
[patent_app_number] => 17/431204
[patent_app_country] => US
[patent_app_date] => 2020-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431204
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/431204 | Cosmetic composition | Feb 28, 2020 | Issued |
Array
(
[id] => 17235568
[patent_doc_number] => 11179431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Bioactive fraction of
[patent_app_type] => utility
[patent_app_number] => 16/801825
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 3575
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16801825
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/801825 | Bioactive fraction of | Feb 25, 2020 | Issued |
Array
(
[id] => 16734415
[patent_doc_number] => 10960036
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-30
[patent_title] => Pharmaceutical composition for preventing and treating alpha herpes virus infection, containing, as active ingredient,
[patent_app_type] => utility
[patent_app_number] => 16/796062
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9346
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796062
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/796062 | Pharmaceutical composition for preventing and treating alpha herpes virus infection, containing, as active ingredient, | Feb 19, 2020 | Issued |
Array
(
[id] => 17466737
[patent_doc_number] => 11273194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-15
[patent_title] => Pharmaceutical composition containing avocado oil fraction as active ingredient for prevention or treatment of hearing loss
[patent_app_type] => utility
[patent_app_number] => 16/791570
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 5611
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791570
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/791570 | Pharmaceutical composition containing avocado oil fraction as active ingredient for prevention or treatment of hearing loss | Feb 13, 2020 | Issued |
Array
(
[id] => 16086885
[patent_doc_number] => 20200197429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => DIETARY SUPPLEMENT FOR GLYCEMIA CONTROL AND DIABETES PREVENTION
[patent_app_type] => utility
[patent_app_number] => 16/792109
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16792109
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/792109 | Dietary supplement for glycemia control and diabetes prevention | Feb 13, 2020 | Issued |
Array
(
[id] => 16267322
[patent_doc_number] => 20200268809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => Health Supplement Compositions
[patent_app_type] => utility
[patent_app_number] => 16/788565
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788565
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/788565 | Health Supplement Compositions | Feb 11, 2020 | Abandoned |
Array
(
[id] => 17576955
[patent_doc_number] => 20220133810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => LIQUID PROPOLIS EXTRACT, ITS FORMULATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/430567
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430567
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430567 | Liquid propolis extract, its formulation and use thereof | Feb 11, 2020 | Issued |
Array
(
[id] => 17748216
[patent_doc_number] => 20220226419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => A PHARMACEUTICAL KIT FOR ALLEVIATING ADVERSE EFFECTS OF CHEMOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/609673
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609673
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609673 | A PHARMACEUTICAL KIT FOR ALLEVIATING ADVERSE EFFECTS OF CHEMOTHERAPY | Feb 11, 2020 | Pending |
Array
(
[id] => 19870340
[patent_doc_number] => 12263177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => Biologically active ganoderma lucidum compounds and synthesis of anticancer derivatives; ergosterol peroxide probes for cellular localization
[patent_app_type] => utility
[patent_app_number] => 17/428812
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 62
[patent_no_of_words] => 13673
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428812
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428812 | Biologically active ganoderma lucidum compounds and synthesis of anticancer derivatives; ergosterol peroxide probes for cellular localization | Feb 5, 2020 | Issued |
Array
(
[id] => 16153813
[patent_doc_number] => 20200215139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => BLEOMYCIN HYDROLASE PRODUCTION PROMOTOR
[patent_app_type] => utility
[patent_app_number] => 16/783860
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783860
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/783860 | BLEOMYCIN HYDROLASE PRODUCTION PROMOTOR | Feb 5, 2020 | Abandoned |
Array
(
[id] => 15990121
[patent_doc_number] => 20200170931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => SOOTHING CREAM AND MANUFACTURING METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/782670
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782670
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/782670 | SOOTHING CREAM AND MANUFACTURING METHOD THEREOF | Feb 4, 2020 | Abandoned |
Array
(
[id] => 19960378
[patent_doc_number] => 12329850
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Microalgae having high loliolide productivity
[patent_app_type] => utility
[patent_app_number] => 17/427069
[patent_app_country] => US
[patent_app_date] => 2020-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 5232
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/427069 | Microalgae having high loliolide productivity | Jan 30, 2020 | Issued |
Array
(
[id] => 16252155
[patent_doc_number] => 20200261529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => KAVA DERIVED THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/750812
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16750812
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/750812 | Kava derived therapeutic compounds and methods of use thereof | Jan 22, 2020 | Issued |
Array
(
[id] => 17472506
[patent_doc_number] => 20220080010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => NOVEL USE OF SIDA RHOMBIFOLIA
[patent_app_type] => utility
[patent_app_number] => 17/423078
[patent_app_country] => US
[patent_app_date] => 2020-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423078 | Use of | Jan 14, 2020 | Issued |
Array
(
[id] => 17593552
[patent_doc_number] => 20220143125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => FUKE QIANJIN CAPSULE AND QUALITY CONTROL METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/293920
[patent_app_country] => US
[patent_app_date] => 2020-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293920 | Fuke Qianjin Capsule and quality control method therefor | Jan 13, 2020 | Issued |
Array
(
[id] => 17518675
[patent_doc_number] => 20220104523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => FOOD AND BEVERAGE PRODUCTS COMPRISING ASCOMYCETES
[patent_app_type] => utility
[patent_app_number] => 17/421612
[patent_app_country] => US
[patent_app_date] => 2020-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421612
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421612 | FOOD AND BEVERAGE PRODUCTS COMPRISING ASCOMYCETES | Jan 8, 2020 | Abandoned |
Array
(
[id] => 17458622
[patent_doc_number] => 20220071926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => METHOD FOR PRODUCING XANTHOHUMOL-CONTAINING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/417166
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17417166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/417166 | METHOD FOR PRODUCING XANTHOHUMOL-CONTAINING COMPOSITION | Dec 22, 2019 | Abandoned |